Cetera Trust Company’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Cetera Trust Company’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$905	Hold	250	–	–	﹤0.01%	343
2026 Q1	$1.21K	Hold	250	–	–	﹤0.01%	349
2025 Q4	$1.82K	Hold	250	–	–	﹤0.01%	356
2025 Q3	$4.1K	Hold	250	–	–	﹤0.01%	344
2025 Q2	$5.06K	Hold	250	–	–	﹤0.01%	342
2025 Q1	$1.93K	Buy	+250	New	+$1.44K	﹤0.01%	370

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Cetera Trust Company's QNTM Position: Q2 2026 in Review

Cetera Trust Company held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q2 2026 at 250 shares worth $905. The position accounts for ﹤0.01% of the portfolio, ranked #343.

Cetera Trust Company first reported a position in QNTM in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.06K in Q2 2025. 26 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

Cetera Trust Company held 250 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $905 as of Q2 2026.
Cetera Trust Company left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q2 2026.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Cetera Trust Company's portfolio in Q2 2026, its #343 holding.
Cetera Trust Company first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 6 quarters since.
Cetera Trust Company's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $5.06K in Q2 2025.
26 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Cetera Trust Company's 13F filing for Q2 2026, filed 13 Aug 2026.